The Group's principal activity is to provide kidney dialysis treatment and manufacturing dialysis products such as hemodialysis machines, dialyzers and related disposable products. The Group provides a complete range of products for treatment of chronic kidney failure through hemodialysis and peritoneal dialysis. The dialysis treatment has been provided to patients at over 1,610 clinics located in 26 countries. The Group also provides inpatient dialysis services, therapeutic apheresis and other services. The Group has its operations in North America, Europe and Asia Pacific.
Alacra Alerts:
Receive alerts on the latest reports on Fresenius Medical Care AG & Co. KGaA
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
